HEADER TRANSFERASE/TRANSFERASE INHIBITOR 29-AUG-12 4GU6 TITLE FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH N-{3-[(5-CYANO- TITLE 2 2-PHENYL-1H-PYRROLO[2,3-B]PYRIDIN-4-YLAMINO)- METHYL]-PYRIDIN-2-YL}- TITLE 3 N-METHYL-METHANESULFONAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: FOCAL ADHESION KINASE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 411-689; COMPND 5 SYNONYM: FADK 1, FOCAL ADHESION KINASE-RELATED NONKINASE, FRNK, COMPND 6 PROTEIN PHOSPHATASE 1 REGULATORY SUBUNIT 71, PPP1R71, PROTEIN- COMPND 7 TYROSINE KINASE 2, P125FAK, PP125FAK; COMPND 8 EC: 2.7.10.2; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PTK2, FAK, FAK1; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS PROTEIN TYROSINE KINASE, ATP BINDING, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.MUSIL,T.HEINRICH REVDAT 2 13-SEP-23 4GU6 1 REMARK SEQADV REVDAT 1 04-SEP-13 4GU6 0 JRNL AUTH T.HEINRICH,J.SEENISAMY,L.EMMANUVEL,S.S.KULKARNI,J.BOMKE, JRNL AUTH 2 F.ROHDICH,H.GREINER,C.ESDAR,M.KRIER,U.GRADLER,D.MUSIL JRNL TITL FRAGMENT-BASED DISCOVERY OF NEW HIGHLY SUBSTITUTED JRNL TITL 2 1H-PYRROLO[2,3-B]- AND 3H-IMIDAZOLO[4,5-B]-PYRIDINES AS JRNL TITL 3 FOCAL ADHESION KINASE INHIBITORS. JRNL REF J.MED.CHEM. V. 56 1160 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 23294348 JRNL DOI 10.1021/JM3016014 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.1 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 42947 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.171 REMARK 3 R VALUE (WORKING SET) : 0.170 REMARK 3 FREE R VALUE : 0.194 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.040 REMARK 3 FREE R VALUE TEST SET COUNT : 2165 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.00 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3118 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1804 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2957 REMARK 3 BIN R VALUE (WORKING SET) : 0.1781 REMARK 3 BIN FREE R VALUE : 0.2242 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.16 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 161 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4254 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 62 REMARK 3 SOLVENT ATOMS : 343 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.48 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.66 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.82140 REMARK 3 B22 (A**2) : 0.92910 REMARK 3 B33 (A**2) : 0.89230 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.217 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.144 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.953 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.944 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4432 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6002 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1566 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 102 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 638 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4432 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 561 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5454 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.98 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.00 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.68 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|414 - A|686 } REMARK 3 ORIGIN FOR THE GROUP (A): 12.2835 -7.9474 -38.0114 REMARK 3 T TENSOR REMARK 3 T11: -0.0931 T22: -0.0308 REMARK 3 T33: -0.0477 T12: -0.0006 REMARK 3 T13: -0.0176 T23: -0.0086 REMARK 3 L TENSOR REMARK 3 L11: 1.0481 L22: 1.4180 REMARK 3 L33: 0.6963 L12: 0.3354 REMARK 3 L13: -0.0682 L23: -0.1757 REMARK 3 S TENSOR REMARK 3 S11: 0.0576 S12: -0.0756 S13: 0.0058 REMARK 3 S21: 0.0917 S22: -0.1204 S23: -0.1048 REMARK 3 S31: 0.0436 S32: 0.0968 S33: 0.0628 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|415 - B|686 } REMARK 3 ORIGIN FOR THE GROUP (A): -10.9491 2.8817 -9.4802 REMARK 3 T TENSOR REMARK 3 T11: -0.0272 T22: -0.1313 REMARK 3 T33: -0.1436 T12: 0.0325 REMARK 3 T13: -0.0057 T23: -0.0620 REMARK 3 L TENSOR REMARK 3 L11: 2.5225 L22: 0.8560 REMARK 3 L33: 1.9523 L12: 0.6650 REMARK 3 L13: -0.4337 L23: -0.0932 REMARK 3 S TENSOR REMARK 3 S11: -0.0515 S12: -0.2183 S13: 0.1889 REMARK 3 S21: 0.0599 S22: 0.0303 S23: 0.0246 REMARK 3 S31: -0.2191 S32: -0.1144 S33: 0.0211 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4GU6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-SEP-12. REMARK 100 THE DEPOSITION ID IS D_1000074636. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-APR-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42948 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 48.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 13.00 REMARK 200 R MERGE (I) : 0.08900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.08 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 13.30 REMARK 200 R MERGE FOR SHELL (I) : 0.50800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 3PXK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.57 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS, 16% PEG 3350, PH 8.6, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.68900 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 96.44050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.84900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 96.44050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.68900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 27.84900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 408 REMARK 465 SER A 409 REMARK 465 GLY A 410 REMARK 465 SER A 411 REMARK 465 THR A 412 REMARK 465 ARG A 413 REMARK 465 PRO A 444 REMARK 465 GLU A 445 REMARK 465 GLN A 687 REMARK 465 GLU A 688 REMARK 465 GLU A 689 REMARK 465 GLY B 408 REMARK 465 SER B 409 REMARK 465 GLY B 410 REMARK 465 SER B 411 REMARK 465 THR B 412 REMARK 465 ARG B 413 REMARK 465 ASP B 414 REMARK 465 TYR B 570 REMARK 465 MET B 571 REMARK 465 GLU B 572 REMARK 465 ASP B 573 REMARK 465 SER B 574 REMARK 465 THR B 575 REMARK 465 TYR B 576 REMARK 465 TYR B 577 REMARK 465 LYS B 578 REMARK 465 ALA B 579 REMARK 465 SER B 580 REMARK 465 LYS B 581 REMARK 465 GLY B 582 REMARK 465 LYS B 583 REMARK 465 GLN B 687 REMARK 465 GLU B 688 REMARK 465 GLU B 689 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 545 -17.12 84.03 REMARK 500 CYS B 459 0.43 -68.62 REMARK 500 ARG B 545 -11.87 78.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 10N A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 10N B 701 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3PXK RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN COMPLEX WITH PYRROLO[2,3-D]THIAZOLE DBREF 4GU6 A 411 689 UNP Q05397 FAK1_HUMAN 411 689 DBREF 4GU6 B 411 689 UNP Q05397 FAK1_HUMAN 411 689 SEQADV 4GU6 GLY A 408 UNP Q05397 EXPRESSION TAG SEQADV 4GU6 SER A 409 UNP Q05397 EXPRESSION TAG SEQADV 4GU6 GLY A 410 UNP Q05397 EXPRESSION TAG SEQADV 4GU6 GLY B 408 UNP Q05397 EXPRESSION TAG SEQADV 4GU6 SER B 409 UNP Q05397 EXPRESSION TAG SEQADV 4GU6 GLY B 410 UNP Q05397 EXPRESSION TAG SEQRES 1 A 282 GLY SER GLY SER THR ARG ASP TYR GLU ILE GLN ARG GLU SEQRES 2 A 282 ARG ILE GLU LEU GLY ARG CYS ILE GLY GLU GLY GLN PHE SEQRES 3 A 282 GLY ASP VAL HIS GLN GLY ILE TYR MET SER PRO GLU ASN SEQRES 4 A 282 PRO ALA LEU ALA VAL ALA ILE LYS THR CYS LYS ASN CYS SEQRES 5 A 282 THR SER ASP SER VAL ARG GLU LYS PHE LEU GLN GLU ALA SEQRES 6 A 282 LEU THR MET ARG GLN PHE ASP HIS PRO HIS ILE VAL LYS SEQRES 7 A 282 LEU ILE GLY VAL ILE THR GLU ASN PRO VAL TRP ILE ILE SEQRES 8 A 282 MET GLU LEU CYS THR LEU GLY GLU LEU ARG SER PHE LEU SEQRES 9 A 282 GLN VAL ARG LYS TYR SER LEU ASP LEU ALA SER LEU ILE SEQRES 10 A 282 LEU TYR ALA TYR GLN LEU SER THR ALA LEU ALA TYR LEU SEQRES 11 A 282 GLU SER LYS ARG PHE VAL HIS ARG ASP ILE ALA ALA ARG SEQRES 12 A 282 ASN VAL LEU VAL SER SER ASN ASP CYS VAL LYS LEU GLY SEQRES 13 A 282 ASP PHE GLY LEU SER ARG TYR MET GLU ASP SER THR TYR SEQRES 14 A 282 TYR LYS ALA SER LYS GLY LYS LEU PRO ILE LYS TRP MET SEQRES 15 A 282 ALA PRO GLU SER ILE ASN PHE ARG ARG PHE THR SER ALA SEQRES 16 A 282 SER ASP VAL TRP MET PHE GLY VAL CYS MET TRP GLU ILE SEQRES 17 A 282 LEU MET HIS GLY VAL LYS PRO PHE GLN GLY VAL LYS ASN SEQRES 18 A 282 ASN ASP VAL ILE GLY ARG ILE GLU ASN GLY GLU ARG LEU SEQRES 19 A 282 PRO MET PRO PRO ASN CYS PRO PRO THR LEU TYR SER LEU SEQRES 20 A 282 MET THR LYS CYS TRP ALA TYR ASP PRO SER ARG ARG PRO SEQRES 21 A 282 ARG PHE THR GLU LEU LYS ALA GLN LEU SER THR ILE LEU SEQRES 22 A 282 GLU GLU GLU LYS ALA GLN GLN GLU GLU SEQRES 1 B 282 GLY SER GLY SER THR ARG ASP TYR GLU ILE GLN ARG GLU SEQRES 2 B 282 ARG ILE GLU LEU GLY ARG CYS ILE GLY GLU GLY GLN PHE SEQRES 3 B 282 GLY ASP VAL HIS GLN GLY ILE TYR MET SER PRO GLU ASN SEQRES 4 B 282 PRO ALA LEU ALA VAL ALA ILE LYS THR CYS LYS ASN CYS SEQRES 5 B 282 THR SER ASP SER VAL ARG GLU LYS PHE LEU GLN GLU ALA SEQRES 6 B 282 LEU THR MET ARG GLN PHE ASP HIS PRO HIS ILE VAL LYS SEQRES 7 B 282 LEU ILE GLY VAL ILE THR GLU ASN PRO VAL TRP ILE ILE SEQRES 8 B 282 MET GLU LEU CYS THR LEU GLY GLU LEU ARG SER PHE LEU SEQRES 9 B 282 GLN VAL ARG LYS TYR SER LEU ASP LEU ALA SER LEU ILE SEQRES 10 B 282 LEU TYR ALA TYR GLN LEU SER THR ALA LEU ALA TYR LEU SEQRES 11 B 282 GLU SER LYS ARG PHE VAL HIS ARG ASP ILE ALA ALA ARG SEQRES 12 B 282 ASN VAL LEU VAL SER SER ASN ASP CYS VAL LYS LEU GLY SEQRES 13 B 282 ASP PHE GLY LEU SER ARG TYR MET GLU ASP SER THR TYR SEQRES 14 B 282 TYR LYS ALA SER LYS GLY LYS LEU PRO ILE LYS TRP MET SEQRES 15 B 282 ALA PRO GLU SER ILE ASN PHE ARG ARG PHE THR SER ALA SEQRES 16 B 282 SER ASP VAL TRP MET PHE GLY VAL CYS MET TRP GLU ILE SEQRES 17 B 282 LEU MET HIS GLY VAL LYS PRO PHE GLN GLY VAL LYS ASN SEQRES 18 B 282 ASN ASP VAL ILE GLY ARG ILE GLU ASN GLY GLU ARG LEU SEQRES 19 B 282 PRO MET PRO PRO ASN CYS PRO PRO THR LEU TYR SER LEU SEQRES 20 B 282 MET THR LYS CYS TRP ALA TYR ASP PRO SER ARG ARG PRO SEQRES 21 B 282 ARG PHE THR GLU LEU LYS ALA GLN LEU SER THR ILE LEU SEQRES 22 B 282 GLU GLU GLU LYS ALA GLN GLN GLU GLU HET 10N A 701 31 HET 10N B 701 31 HETNAM 10N N-(3-{[(5-CYANO-2-PHENYL-1H-PYRROLO[2,3-B]PYRIDIN-4- HETNAM 2 10N YL)AMINO]METHYL}PYRIDIN-2-YL)-N- HETNAM 3 10N METHYLMETHANESULFONAMIDE FORMUL 3 10N 2(C22 H20 N6 O2 S) FORMUL 5 HOH *343(H2 O) HELIX 1 1 GLN A 418 GLU A 420 5 3 HELIX 2 2 SER A 461 GLN A 477 1 17 HELIX 3 3 GLU A 506 ARG A 514 1 9 HELIX 4 4 ASP A 519 LYS A 540 1 22 HELIX 5 5 ALA A 548 ARG A 550 5 3 HELIX 6 6 ASP A 564 ARG A 569 1 6 HELIX 7 7 ARG A 569 SER A 574 1 6 HELIX 8 8 THR A 575 TYR A 577 5 3 HELIX 9 9 PRO A 585 MET A 589 5 5 HELIX 10 10 ALA A 590 ARG A 597 1 8 HELIX 11 11 THR A 600 MET A 617 1 18 HELIX 12 12 LYS A 627 ASN A 629 5 3 HELIX 13 13 ASP A 630 ASN A 637 1 8 HELIX 14 14 PRO A 648 TRP A 659 1 12 HELIX 15 15 ASP A 662 ARG A 666 5 5 HELIX 16 16 ARG A 668 ALA A 685 1 18 HELIX 17 17 GLN B 418 GLU B 420 5 3 HELIX 18 18 SER B 461 GLN B 477 1 17 HELIX 19 19 GLU B 506 ARG B 514 1 9 HELIX 20 20 ASP B 519 LYS B 540 1 22 HELIX 21 21 ALA B 548 ARG B 550 5 3 HELIX 22 22 PRO B 585 MET B 589 5 5 HELIX 23 23 ALA B 590 ARG B 597 1 8 HELIX 24 24 THR B 600 MET B 617 1 18 HELIX 25 25 LYS B 627 ASN B 629 5 3 HELIX 26 26 ASP B 630 ASN B 637 1 8 HELIX 27 27 PRO B 648 TRP B 659 1 12 HELIX 28 28 ASP B 662 ARG B 666 5 5 HELIX 29 29 ARG B 668 ALA B 685 1 18 SHEET 1 A 5 ILE A 422 GLY A 431 0 SHEET 2 A 5 GLY A 434 TYR A 441 -1 O GLN A 438 N ARG A 426 SHEET 3 A 5 LEU A 449 THR A 455 -1 O LEU A 449 N TYR A 441 SHEET 4 A 5 TRP A 496 GLU A 500 -1 O MET A 499 N ALA A 452 SHEET 5 A 5 LEU A 486 ILE A 490 -1 N GLY A 488 O ILE A 498 SHEET 1 B 2 VAL A 552 SER A 556 0 SHEET 2 B 2 CYS A 559 LEU A 562 -1 O LYS A 561 N LEU A 553 SHEET 1 C 5 ILE B 422 GLY B 431 0 SHEET 2 C 5 GLY B 434 SER B 443 -1 O VAL B 436 N ILE B 428 SHEET 3 C 5 ASN B 446 THR B 455 -1 O ILE B 453 N HIS B 437 SHEET 4 C 5 TRP B 496 GLU B 500 -1 O MET B 499 N ALA B 452 SHEET 5 C 5 LEU B 486 ILE B 490 -1 N GLY B 488 O ILE B 498 SHEET 1 D 2 VAL B 552 SER B 556 0 SHEET 2 D 2 CYS B 559 LEU B 562 -1 O LYS B 561 N LEU B 553 SSBOND 1 CYS A 456 CYS A 459 1555 1555 2.04 SSBOND 2 CYS B 456 CYS B 459 1555 1555 2.04 CISPEP 1 ASN A 493 PRO A 494 0 -2.51 CISPEP 2 ASN B 493 PRO B 494 0 -2.11 SITE 1 AC1 15 GLU A 430 ASN A 493 GLU A 500 LEU A 501 SITE 2 AC1 15 CYS A 502 THR A 503 GLY A 505 ARG A 550 SITE 3 AC1 15 ASN A 551 LEU A 553 GLY A 563 ASP A 564 SITE 4 AC1 15 LEU A 567 SER A 568 HOH A1012 SITE 1 AC2 15 ILE B 428 GLU B 430 GLU B 500 LEU B 501 SITE 2 AC2 15 CYS B 502 THR B 503 GLY B 505 GLU B 506 SITE 3 AC2 15 ARG B 550 ASN B 551 LEU B 553 GLY B 563 SITE 4 AC2 15 ASP B 564 LEU B 567 SER B 568 CRYST1 53.378 55.698 192.881 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018734 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017954 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005185 0.00000